NVNO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
enVVeno Medical Corp (NVNO) is not a strong buy for a beginner, long-term investor at this moment. The lack of significant positive catalysts, poor financial performance, and absence of strong trading signals suggest holding off on investment until better opportunities arise.
The MACD is positive and expanding, indicating a bullish trend. RSI is neutral at 68.093, and moving averages are converging, showing no clear directional momentum. Key resistance is at 12.293, which aligns with the current pre-market price of 12.3, suggesting limited immediate upside.
NULL identified. No recent news or significant insider/hedge fund activity. Technical indicators show slight bullishness, but not enough to warrant a strong buy.
Financial performance is weak with declining net income (-19.55% YoY) and EPS (-35.88% YoY). Revenue remains at 0, and there is no valuation data available. No recent congress trading data or influential figure activity.
In Q3 2025, revenue remained at 0 with no YoY growth. Net income dropped to -$4,539,000 (-19.55% YoY), and EPS fell to -7.88 (-35.88% YoY). Gross margin remains at 0, indicating no profitability.
No data on analyst ratings or price target changes available.
